Additionally, TsAg conferred a therapeutic effect on sepsis-induced acute lung injury through activating Tregs and inhibiting pro-inflammatory cytokinesvia the high mobility group box 1/TLR2/MYD88 signaling pathway[123]. The gene discussed is TLR2; the disease is Sepsis.